Susquehanna International Group
TARA icon

Susquehanna International Group’s Protara Therapeutics TARA Stock Holding History

Susquehanna International Group’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$608K Buy
116,626
+9,780
+9% +$57.9K ﹤0.01% 9159
2025
Q4 		$569K Buy
106,846
+25,643
+32% +$143K ﹤0.01% 8474
2025
Q3 		$353K Sell
81,203
-138,694
-63% -$449K ﹤0.01% 9743
2025
Q2 		$666K Sell
219,897
-54,984
-20% -$190K ﹤0.01% 8497
2025
Q1 		$1.17M Buy
274,881
+56,408
+26% +$252K ﹤0.01% 6860
2024
Q4 		$1.15M Buy
+218,473
New +$706K ﹤0.01% 6602
2024
Q3 		– Sell
-10,036
Closed -$20.9K – 13021
2024
Q2 		$20.9K Sell
10,036
-1,149
-10% -$3.36K ﹤0.01% 11659
2024
Q1 		$44.9K Buy
+11,185
New +$36.1K ﹤0.01% 11597
2023
Q4 		– Sell
-34,971
Closed -$58.4K – 13273
2023
Q3 		$58.4K Buy
+34,971
New +$80.1K ﹤0.01% 11222
2022
Q3 		– Sell
-15,969
Closed -$47K – 14107
2022
Q2 		$47K Buy
15,969
+2,230
+16% +$8.15K ﹤0.01% 12013
2022
Q1 		$70K Sell
13,739
-14,123
-51% -$74.2K ﹤0.01% 12133
2021
Q4 		$188K Buy
27,862
+11,969
+75% +$82.5K ﹤0.01% 11517
2021
Q3 		$110K Sell
15,893
-4,716
-23% -$36.8K ﹤0.01% 12005
2021
Q2 		$201K Buy
+20,609
New +$233K ﹤0.01% 11595
2020
Q2 		– Sell
-18,674
Closed -$441K – 10905
2020
Q1 		$441K Buy
18,674
+18,264
+4,455% +$532K ﹤0.01% 7199
2019
Q4 		$7K Sell
410
-1,491
-78% -$17.1K ﹤0.01% 9568
2019
Q3 		$20K Buy
+1,901
New +$27.2K ﹤0.01% 9950
2019
Q1 		– Sell
-802
Closed -$73K – 9823
2018
Q4 		$73K Buy
+802
New +$56.6K ﹤0.01% 8351
2018
Q2 		– Sell
-307
Closed -$31K – 10405
2018
Q1 		$31K Sell
307
-186
-38% -$16.9K ﹤0.01% 9068
2017
Q4 		$37K Buy
+493
New +$39.5K ﹤0.01% 8986
2017
Q2 		– Sell
-739
Closed -$52K – 9822
2017
Q1 		$52K Buy
+739
New +$55.2K ﹤0.01% 8583

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Susquehanna International Group's TARA Position: Q1 2026 in Review

Susquehanna International Group increased its Protara Therapeutics (TARA) stake by 9.2% in Q1 2026, buying an estimated $57.9K and bringing the position to 116,626 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #9159.

Susquehanna International Group first reported a position in TARA in Q1 2017 and has held it in 21 quarters since. The position peaked at $1.17M in Q1 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Susquehanna International Group held 116,626 shares of Protara Therapeutics worth $608K as of Q1 2026.
  • Susquehanna International Group bought 9,780 Protara Therapeutics shares in Q1 2026, an estimated $57.9K.
  • Protara Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9159 holding.
  • Susquehanna International Group first reported a position in Protara Therapeutics in Q1 2017 and has held it in 21 quarters since.
  • Susquehanna International Group's Protara Therapeutics position peaked at $1.17M in Q1 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.